Atlas Trials

Vinorelbine in Relapsed Platinum Resistant or Refractory C5 High Grade Serous, Endometrioid, or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian Cancer

Clinical trial NCT03188159 · UNKNOWN

Trial details

NCT number
NCT03188159
Sponsor
National University Hospital, Singapore
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Ovarian CancerFallopian Tube Cancer
Start date
2017-07-01
Primary completion
2021-07-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.